SCHEMBL4152810

SCHEMBL4152810

COc1c(C(=O)NC2CC2)ccc2[nH]nc(/C=C/c3ccccc3CO)c12

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A12 P48065 1/20 0.42
KDR P35968 1/20 0.40
DRD3 P35462 1/20 0.39
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 1/20 0.38
CYP3A4 P08684 1/20 0.38
SIGMAR1 Q99720 2/20 0.38
PTK2 Q05397 1/20 0.37
DRD4 P21917 2/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TAS1R2 Q8TE23 1/20 0.37
SSTR5 P35346 2/20 0.36
KDM4E B2RXH2 1/20 0.36
SMYD3 Q9H7B4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4152813 1.00 SLC6A12 (0.42) SLC6A12KDRDRD3ALDH1A1NPC1
SCHEMBL4157731 0.88 SLC6A12 (0.48) SLC6A12KDRDRD3ALDH1A1NPC1
SCHEMBL4157738 0.88 SLC6A12 (0.48) SLC6A12KDRDRD3ALDH1A1NPC1
SCHEMBL4153467 0.87 DRD3 (0.42) SLC6A12KDRDRD3ALDH1A1NPC1
SCHEMBL4153464 0.87 DRD3 (0.42) SLC6A12KDRDRD3ALDH1A1NPC1
SCHEMBL4140651 0.85 KDM4E (0.46) SLC6A12KDRDRD3ALDH1A1SIGMAR1
SCHEMBL4140646 0.85 KDM4E (0.46) SLC6A12KDRDRD3ALDH1A1SIGMAR1
SCHEMBL4144793 0.84 DRD3 (0.42) SLC6A12KDRDRD3ALDH1A1SIGMAR1
SCHEMBL4144786 0.84 DRD3 (0.42) SLC6A12KDRDRD3ALDH1A1SIGMAR1
SCHEMBL4153068 0.83 KDR (0.56) SLC6A12KDRPTK2CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND OHI NORIHITO 2009-02-26 US disclosed
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND OHI NORIHITO 2009-02-26 US disclosed
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND OHI NORIHITO 2009-02-26 US disclosed
US-7429609-B2 Pyrazole compound and medicinal composition containing the same EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-30 US disclosed
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed
US-20050208582-A1 Pyrazole compounds and pharmaceutical compositions comprising the compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-09-22 US disclosed
EP-1510516-A1 PYRAZOLE COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME Eisai Co., Ltd. (JP) 2005-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND CNKSR1, NR3C2, CSNK2B SLC6A12 4548/4885KDR 932/4885DRD3 1139/4885
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B SLC6A12 4640/4885KDR 1044/4885DRD3 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.